Its dual role in stimulating AKT/mTOR signaling and modulating myostatin-SMAD pathways highlights its potential as a candidate for combination therapy, potentially engaging novel feedback loops and receptor crosstalk mechanisms relevant to muscle regeneration and anti-cachexia strategies. This evidence concerns the gene AKT1 and Cachexia.